Our 2019 toolkit provides resources for the public to learn about antimicrobial resistance, as well as resources for healthcare, scientific, and administrative professionals.
World Antibiotic Awareness Week 2019 Toolkit
What If We Couldn’t Diagnose Infectious Diseases?
Fundamentally, doctors are blind without diagnostic tools. “It’s like looking for someone in a cave without any light,” says Dr. Mark Miller, Chief Medical Officer at bioMérieux. “You have no idea where you are.”
FDA Approves a New Antibiotic to Treat Pneumonia
Lefamulin’s mechanism of action has a low inclination for developing resistance. The drug is a member of the pleuromutilin antibiotic class, and it has low propensity for cross resistance with a variety of antibiotic classes such as macrolide and tetracycline.
“On the Front Lines” Webinar Series, August 15 – From Theory to Practice with Faster Diagnostics: It Takes a Team
In “From Theory to Practice with Faster Diagnostics: It Takes a Team,” Ravina Kullar, PharmD, MPH, FIDSA, will review the burden of antimicrobial resistance and the importance of early targeted antimicrobial therapy.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...